Shattuck Labs director granted 81,000 stock options

Shattuck Labs, Inc. reported that director Daniel G. Baker received a grant of stock options covering 81,000 shares of common stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Shattuck Labs, Inc. reported that director Daniel G. Baker received a grant of stock options covering 81,000 shares of common stock. The options have an exercise price of $5.95 per share and expire on May 29, 2036.

The award vests in full on the earlier of the one-year anniversary of the grant date or immediately before the company’s next annual meeting of stockholders, as long as Baker continues to serve the company. After this grant, he holds options on 81,000 shares directly.

Insider Trade Summary

Grant/Award: 81,000 shares

Grant/Award 1 txn

Insider Baker Daniel G.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	81,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 81,000 contracts (Direct)

Footnotes (1)

F1. This option represents the right to purchase a total of 81,000 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.

Key Figures

Option grant size: 81,000 shares Exercise price: $5.95 per share Expiration date: May 29, 2036 +1 more

4 metrics

Option grant size 81,000 shares Stock option covering common stock

Exercise price $5.95 per share Stock option strike price

Expiration date May 29, 2036 Option term end

Post-grant derivative holdings 81,000 options Total options held after transaction

Key Terms

Stock Option (Right to Buy), grant/award acquisition, exercise price, vest in full, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

exercise price financial

"conversion_or_exercise_price: "5.9500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in full financial

"which will vest in full on the earlier of the one-year anniversary"

annual meeting of stockholders financial

"immediately prior to the Issuer's next annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Shattuck Labs (STTK) disclose in this Form 4?

Shattuck Labs disclosed that director Daniel G. Baker received a stock option grant for 81,000 shares. The options relate to the company’s common stock and are a compensation award, not an open‑market purchase or sale of existing shares.

How many Shattuck Labs (STTK) shares are covered by Daniel G. Baker’s option grant?

The option grant covers the right to purchase 81,000 shares of Shattuck Labs common stock. This entire amount was awarded in a single grant dated May 29, 2036, according to the Form 4 disclosure.

What is the exercise price of Daniel G. Baker’s Shattuck Labs (STTK) stock options?

The stock options granted to Daniel G. Baker have an exercise price of $5.95 per share. This is the price he must pay per share to convert the options into common stock if he chooses to exercise them.

When do Daniel G. Baker’s Shattuck Labs (STTK) options vest?

The options will vest in full on the earlier of one year after the grant date or immediately before Shattuck Labs’ next annual stockholders’ meeting. Vesting is conditioned on Baker’s continued service with the company through that time.

When do the Shattuck Labs (STTK) stock options granted to Daniel G. Baker expire?

The options granted to Daniel G. Baker expire on May 29, 2036. If he does not exercise them by that expiration date, the right to purchase the 81,000 shares at $5.95 per share will lapse.

Is Daniel G. Baker’s Shattuck Labs (STTK) Form 4 transaction a market purchase or sale?

No, the Form 4 reports a compensation-related stock option grant classified as a grant, award, or other acquisition. It is not an open‑market buy or sell transaction and does not itself involve cash trading of existing shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/02/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baker Daniel G.

(Last)

(First)

(Middle)

C/O SHATTUCK LABS, INC.

500 W. 5TH STREET, SUITE 1200

(Street)

AUSTIN

TEXAS

78701

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Shattuck Labs, Inc. [ STTK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$5.95	05/29/2026		A		81,000		⁽¹⁾	05/29/2036	Common Stock	81,000	$0	81,000	D

Explanation of Responses:

1. This option represents the right to purchase a total of 81,000 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.

	/s/ Andrew R. Neill, Attorney-in-Fact for Dr. Daniel G. Baker	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR